Points to consider in the design and submission of protocols for the transfer of recombinant DNA molecules into one or more human research participants (points to consider). Appendix M
National Institutes of Health [NIH]. (United States). Office of Biotechnology Activities.
Bethesda, MD: National Institutes of Health. Office of Biotechnology Activities; 2002: 15 p.[Online]. Available: http://www4.od.nih.gov/oba/rac/guidelines_02/Appendix_M.htm#_Appe ndix_M-I._Requirements [2005 July 25]
Showing items related by title, author, creator and subject.
Including "Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA into Human Subjects" Minutes of 21 June 1989 Meeting National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee (1989-06-21)